Invex are busting my balls here. This FDA ann will be right on time. If it's one trial, ill hold. If it's 2, ill tax loss it prior to end of month and look to buy back later. Its def good value for someone buying at these levels, super low EV. But I am sitting a solid loss on this ball breaker, so if need be will take the op to play the tax game.
- Forums
- ASX - By Stock
- IXC
- Ann: Invex Granted Type C Meeting with FDA
Ann: Invex Granted Type C Meeting with FDA, page-134
Featured News
Add IXC (ASX) to my watchlist
|
|||||
Last
7.2¢ |
Change
0.002(2.86%) |
Mkt cap ! $5.411M |
Open | High | Low | Value | Volume |
7.0¢ | 7.2¢ | 6.6¢ | $3.476K | 50.58K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 29320 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 8695 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 29320 | 0.070 |
1 | 100000 | 0.066 |
1 | 100000 | 0.065 |
1 | 84879 | 0.063 |
2 | 158500 | 0.060 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 8695 | 1 |
0.080 | 5000 | 1 |
0.090 | 126146 | 1 |
0.095 | 100000 | 1 |
0.100 | 8505 | 2 |
Last trade - 13.58pm 23/08/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online